Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is a parathyroid hormone analog. It stimulates bone formation. It is used to treat osteoporosis.

Question 2

When and how should this medicine be taken?

Accepted Answer

• Give subcutaneously or IV • Follow exact schedule • Store in refrigerator

Question 3

When should this medicine not be used?

Accepted Answer

• In sickle cell disease • During pregnancy/breastfeeding

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• May cause bone pain • Regular blood tests needed • Use carefully in patients with sickle cell disease • May cause allergic reactions • Not recommended during pregnancy or breastfeeding

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Limited data available; • Use with caution; • Consult doctor before use

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• May cause bone pain • Regular blood tests needed • Use carefully in patients with sickle cell disease • May cause allergic reactions • Not recommended during pregnancy or breastfeeding

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For once-daily dosing: If you remember on the same day, take the dose. • For twice-daily dosing: If there's more than 8 hours until your next dose, take the missed dose. • Take your next dose at the regular time. • If you're unsure, contact your doctor or pharmacist.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Overdose symptoms: Leukocytosis, pleural effusion. • Treatment: Dose reduction, monitor WBC count.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Muscle/bone pain, splenic enlargement, nausea, diarrhea, appetite loss, skin conditions, fever• What to do:- Monitor for bone pain- Report unusual bleeding- Regular blood counts- Stay hydrated- Report fever immediately; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Lenograstrim?

Accepted Answer

Lenograstrim (Hematopoietic Drug) is a pharmaceutical active substance. It is indicated for the treatment of Neutropenia, Reduction of Life-Threatening Infection Risk after Cytotoxic Chemotherapy.

Question 11

What is the recommended dosage for Lenograstrim?

Accepted Answer

Standard adult dosage: Intravenous infusion – 19.2 million IU/m2 or 150 mcg/m2 (daily). Pediatric dosage: Intravenous infusion – 19.2 million IU/m2 (daily). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Lenograstrim safe during pregnancy and breastfeeding?

Accepted Answer

Lenograstrim is classified under Pregnancy Category "C". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Lenograstrim?

Accepted Answer

**Musculoskeletal**; Musculoskeletal pain; bone pain; splenic enlargement and osteoporosis; **Gastrointestinal**; Nausea; diarrhea and loss of appetite; **Blood**; Anemia and decrease in platelet counts; **Skin**; Painfu

Clinical Information	Administration Information
Indication: Neutropenia following bone marrow transplantation Age: Adult	Dose: Intravenous infusion – 19.2 million IU/m2 or 150 mcg/m2 Frequency: daily Duration: maximum of 28 consecutive days Note: started the day after transplantation
Indication: Mobilisation of peripheral blood progenitor cells for autologous peripheral blood stem cell transplantation Age: Adult Condition: As monotherapy	Dose: Subcutaneous – 1.28 million IU/kg or 10 mcg/kg Frequency: daily Duration: 4-6 days (5-6 days in healthy donors)

Clinical Information	Administration Information
Indication: Neutropenia following bone marrow transplantation Age: Child: greater than 2 years	Dose: Intravenous infusion – 19.2 million IU/m2 Frequency: daily Duration: for a maximum of 28 consecutive days Note: started the day after transplantation
Indication: Neutropenia following bone marrow transplantation Age: Child: greater than 2 years	Dose: Intravenous infusion – 150 mcg/m2 Frequency: daily Duration: for a maximum of 28 consecutive days Note: started the day after transplantation

Drug Name	Risk Factors
Myelosuppressive antineoplastic agents	Increased risk of myelosuppression
Bleomycin, cyclophosphamide	Increased pulmonary toxicity

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources